Target intelligence / Profile preview

FKBP prolyl isomerase 1A pseudogene 1 (FKBP1AP1)

Target
FKBP1AP1
Molecular classification
Other (Pseudogene, non-coding RNA)
01

Overview

FKBP prolyl isomerase 1A pseudogene 1 is formally listed as a pseudogene, meaning it is a non-coding genomic region with high sequence similarity to the protein-coding gene FKBP1A (FKBP12). Pseudogenes are generally viewed as transcriptionally inactive, but some are known to produce non-coding RNAs that regulate gene expression in other contexts. FKBP1AP1 is not implicated in canonical protein function, receptor action, or drug binding, and is not considered a receptor, enzyme, transporter, or direct disease biomarker. The true drug target in the FKBP family is FKBP1A (FKBP12), which binds immunosuppressive drugs like tacrolimus; FKBP1AP1 does not share this property and is included in molecular family lists only as a genomic annotation. FKBP1AP1 is NOT FKBP1A (FKBP12). FKBP1A is a protein-coding gene and bona fide therapeutic target for immunosuppressants, whereas FKBP1AP1 is a non-functional pseudogene. Most structured information relevant to drug development and biological function for FKBP proteins applies only to FKBP1A, not to FKBP1AP1.

Other names
FKBP12FKBP1P1
02

Mechanism of action

None for drugs targeting this molecule; mechanisms described for FKBP1A (FKBP12), not this pseudogene

03

Biological functions

Potential regulation of gene expression through non-coding RNA mechanisms; pseudogenes can function as microRNA decoys or sources of regulatory RNAs, but specific functions for FKBP1AP1 are not documented in the literature
04

Disease associations

No established disease roles; not implicated in direct disease models, pathology, or therapeutic programs

Beyond the preview

Go deeper on FKBP prolyl isomerase 1A pseudogene 1 (FKBP1AP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FKBP prolyl isomerase 1A pseudogene 1 (FKBP1AP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call